Cetera Investment Advisers
CRL icon

Cetera Investment Advisers’s Charles River Laboratories CRL Stock Holding History

Cetera Investment Advisers’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
7,730
+702
+10% +$125K ﹤0.01% 2499
2026
Q1 		$1.21M Sell
7,028
-97
-1% -$18K ﹤0.01% 2737
2025
Q4 		$1.42M Buy
7,125
+502
+8% +$91.1K ﹤0.01% 2523
2025
Q3 		$1.04M Buy
6,623
+1,775
+37% +$282K ﹤0.01% 2738
2025
Q2 		$736K Sell
4,848
-4,816
-50% -$642K ﹤0.01% 2664
2025
Q1 		$1.45M Buy
9,664
+660
+7% +$111K ﹤0.01% 1977
2024
Q4 		$1.66M Sell
9,004
-1,099
-11% -$212K ﹤0.01% 1791
2024
Q3 		$1.99M Buy
10,103
+134
+1% +$27.8K ﹤0.01% 1636
2024
Q2 		$2.06M Buy
9,969
+229
+2% +$51.9K ﹤0.01% 1549
2024
Q1 		$2.64M Buy
9,740
+6,728
+223% +$1.61M 0.01% 1360
2023
Q4 		$712K Buy
3,012
+202
+7% +$39.7K 0.01% 1301
2023
Q3 		$551K Buy
2,810
+18
+0.6% +$3.69K ﹤0.01% 1368
2023
Q2 		$587K Buy
2,792
+993
+55% +$198K ﹤0.01% 1360
2023
Q1 		$363K Sell
1,799
-81
-4% -$18.4K ﹤0.01% 1602
2022
Q4 		$410K Buy
1,880
+517
+38% +$113K ﹤0.01% 1483
2022
Q3 		$268K Sell
1,363
-115
-8% -$24.8K 0.01% 1349
2022
Q2 		$316K Buy
1,478
+57
+4% +$13.9K 0.01% 1384
2022
Q1 		$404K Sell
1,421
-1,212
-46% -$374K 0.01% 1303
2021
Q4 		$992K Sell
2,633
-219
-8% -$85.1K 0.01% 807
2021
Q3 		$1.18M Sell
2,852
-21
-0.7% -$8.72K 0.02% 717
2021
Q2 		$1.06M Buy
2,873
+1,081
+60% +$361K 0.02% 751
2021
Q1 		$519K Buy
1,792
+63
+4% +$17.5K 0.01% 960
2020
Q4 		$432K Buy
+1,729
New +$412K 0.01% 1030

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Cetera Investment Advisers's CRL Position: Q2 2026 in Review

Cetera Investment Advisers increased its Charles River Laboratories (CRL) stake by 10% in Q2 2026, buying an estimated $125K and bringing the position to 7,730 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Cetera Investment Advisers first reported a position in CRL in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.64M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Cetera Investment Advisers held 7,730 shares of Charles River Laboratories worth $1.75M as of Q2 2026.
  • Cetera Investment Advisers bought 702 Charles River Laboratories shares in Q2 2026, an estimated $125K.
  • Charles River Laboratories made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2499 holding.
  • Cetera Investment Advisers first reported a position in Charles River Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's Charles River Laboratories position peaked at $2.64M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.